Nureca · NSE: NURECA · BSE: 543264

Q4 FY22 results · Jan–Mar 2022

Nureca reported revenue from operations of ₹41.05 crore (up 28.9% from Q4 FY21) and net loss of ₹1.40 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations41.0531.84+28.9%48.08−14.6%
Other income1.711.28+33.7%1.74−1.5%
Total income42.7633.12+29.1%49.81−14.2%
Profit before tax(1.91)5.20Turned loss6.32Turned loss
Net profit for the period(1.40)3.89Turned loss4.73Turned loss
EPS, basic (₹)(1.40)4.56Turned loss4.73Turned loss
Net margin (%)-3.412.29.8
Standalone · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations41.0831.82+29.1%48.08−14.6%
Other income1.711.28+34.0%1.75−1.8%
Total income42.7933.10+29.3%49.82−14.1%
Profit before tax(1.67)5.13Turned loss6.42Turned loss
Net profit for the period(1.17)3.82Turned loss4.84Turned loss
EPS, basic (₹)(1.17)4.48Turned loss4.84Turned loss
Net margin (%)-2.812.010.1
Consolidated
Filed with BSE
10 Jun 2022, 12:49 IST
Board meeting
28 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
10 Jun 2022, 12:49 IST
Board meeting
28 May 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE